pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 9·1 min read
save

White House reviews three candidates to lead the FDA

Jul 9, 2026·read at STAT ↗RegulatoryNeutral

STAT+ reports that the White House is currently evaluating three leading candidates to become the next head of the Food and Drug Administration. The review process is part of the administration's effort to select new leadership for the agency.

The information comes from the D.C. Diagnosis newsletter, authored by John Wilkerson, who covers health‑care policy and politics. The article notes that the candidates are considered top contenders for the role.

The piece is available to STAT+ subscribers and includes background on the newsletter and subscription options, but the core news is the ongoing review of the FDA leadership finalists.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: FDA finalists under review”

read at STAT ↗
415 words · retrieved Jul 9
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Beam Therapeutics Inc.LEADINGPATH
topics
Major Depression

related stories

  • 20h agoGSK laying off 1.2K+ in BelgiumBioSpace
  • Sep 23Opinion: Mentally ill women deserve more support to have childrenSTAT
  • Sep 17Longeveron’s shares crash as stem cell therapy flunks mid-stage cardio trialBioSpace
  • Jul 16J&J sees Spravato sales surge as psychedelic competitors loomBioSpace
  • Jul 8Bryan Johnson’s chronic disease is notoriously difficult to diagnoseSTAT